EMA: Draft guideline on the quality, non-clinical and clinical aspects of gene therapy medicinal products

This guideline defines scientific principles and provides guidance for the development and evaluation of gene therapy medicinal products (GTMP) intended for use in humans and presented for marketing authorisation. Its focus is on the quality, safety and efficacy requirements of GTMPs.